• Aflac posted Q2 2026 adjusted EPS of $1.80, up 1.1% excluding foreign-currency effects; variable investment income missed its long-term expectation by $72 million.
• Reserve remeasurement gains totaled $46 million, cutting benefits; an expense contingency release of $26 million lifted results by $0.04 per share.
• Japan: net earned premiums fell 3.7% in yen terms; underlying earned premiums slipped 1.4%; benefit ratio improved to 64% as cancer and hospitalization trends stayed favorable.
• U.S.: net earned premiums rose 2.3%; benefit ratio increased to 49.5% on higher group disability claims; expense ratio improved to 36.1%.
• Investment actions included $4.8 billion of switch trades; the repositioning is expected to add over $50 million in annualized net investment income on a run-rate basis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aflac Incorporated published the original content used to generate this news brief on August 07, 2026, and is solely responsible for the information contained therein.